Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1998; 79(04): 884
DOI: 10.1055/s-0037-1615087
DOI: 10.1055/s-0037-1615087
Letters to the Editor
What Is the Tasman Trial?
Further Information
Publication History
Received
13 November 1997
Accepted
14 November 1997
Publication Date:
07 December 2017 (online)
-
References
- 1 Graafsma YF, Prins MH, Lensing AWA, de Haan RJ, Huisman MV, Büller HR. Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost 1998; 78: 1189-92.
- 2 Koopman MMW, Prandoni P, Piovella F. et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682-7.
- 3 International Committee of Medical Journal Editors.. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1991; 324: 424-8.
- 4 Cheng TO. Acronym aggravation. Br Heart J 1994; 71: 107-9.
- 5 Cheng TO. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice. Cardiology 1996; 87: 267.
- 6 Cheng TO. Acronymophilia: the exponential growth of the use of acronyms should be resisted. Br Med J 1994; 309: 683-4.